ENIGMATIG LTD-A(US:EGG)2025-08-28 22:00Financial Performance Summary - Enero Group's net revenue from continuing operations decreased by 3% from A$143.5 million in FY24 to A$138.7 million in FY25[39] - EBITDA from continuing operations increased by 2% from A$13.9 million in FY24 to A$14.1 million in FY25[39] - EBITDA margin from continuing operations increased by 0.5 percentage points, from 9.7% in FY24 to 10.2% in FY25[39] - Including discontinuing operations (OBMedia), net revenue decreased by 11% from A$189.7 million in FY24 to A$168.3 million in FY25[39] - Including discontinuing operations, EBITDA decreased by 30% from A$37.4 million in FY24 to A$26.2 million in FY25[39] - Including discontinuing operations, EBITDA margin decreased by 4.1 percentage points, from 19.7% in FY24 to 15.5% in FY25[39] Segment Performance - The Technology, Healthcare & Consumer (THC) Practice saw a 3% decrease in revenue, from A$143.5 million to A$138.7 million, but EBITDA increased slightly by 0.2% from A$22.8 million to A$22.9 million[40] - Hotwire Global's revenue decreased by 4% from A$81.7 million to A$78.6 million, but EBITDA increased by 15% from A$9.6 million to A$11.1 million[12] - BMF's revenue decreased by 2% from A$35.0 million to A$34.4 million, and EBITDA decreased by 14% from A$8.0 million to A$6.9 million[12] Half-on-Half Performance - In the THC Practice, H2 revenue increased by 2% compared to H1 (A$70.1 million vs A$68.7 million)[8] - The THC Practice's EBITDA margin improved by 1.7 percentage points from H1 to H2 (9.3% vs 11.0%)[8] - Corporate costs reduced 24% in FY25 H2 on prior half and in FY25 H2 represents 4.7% of revenue (excluding share-based payments)[9]